Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen W Duffy

Showing results (21-30 of 294) with videos related to

Pageof 30
Sort By:
Journal of Medical Screening|March 5, 2016
Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening ProgrammeDimitrios Michalopoulos, Stephen W Duffy
The Lancet. Oncology|November 5, 2020
Mammography screening for breast cancer-the UK Age trial - Authors' replyStephen W Duffy, Peter D Sasieni
The New England Journal of Medicine|January 30, 2020
Mortality Reduction with Low-Dose CT Screening for Lung CancerStephen W Duffy, John K Field
The Medical Clinics of North America|October 25, 2020
The Evaluation of Cancer Screening: Concepts and Outcome MeasuresStephen W Duffy, Robert A Smith
Journal of Medical Screening|December 13, 2021
When primary prevention replaces screeningStephen W Duffy, Nicholas J Wald
Journal of Medical Screening|March 14, 2015
A note on the design of cancer screening trialsStephen W Duffy, Robert A Smith
Thorax|June 30, 2018
Lung cancer CT screening: are we ready to consider screening biennially in a subgroup of low-risk individuals?John K Field, Stephen W Duffy
The New England Journal of Medicine|January 21, 2011
More on screening mammographyStephen W Duffy, Robert A Smith
The Lancet. Oncology|March 25, 2016
Lung cancer CT screening: is annual screening necessary?John K Field, Stephen W Duffy
The Lancet Regional Health. Europe|December 24, 2021
Understanding the lung cancer mortality reductions produced by low-dose CT screening-Authors' replyStephen W Duffy, John K Field
Pageof 30

Showing results (21-30 of 294) with videos related to

Sort By:
Pageof 30
Journal of Medical Screening|March 5, 2016
Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening ProgrammeDimitrios Michalopoulos, Stephen W Duffy
The Lancet. Oncology|November 5, 2020
Mammography screening for breast cancer-the UK Age trial - Authors' replyStephen W Duffy, Peter D Sasieni
The New England Journal of Medicine|January 30, 2020
Mortality Reduction with Low-Dose CT Screening for Lung CancerStephen W Duffy, John K Field
The Medical Clinics of North America|October 25, 2020
The Evaluation of Cancer Screening: Concepts and Outcome MeasuresStephen W Duffy, Robert A Smith
Journal of Medical Screening|December 13, 2021
When primary prevention replaces screeningStephen W Duffy, Nicholas J Wald
Journal of Medical Screening|March 14, 2015
A note on the design of cancer screening trialsStephen W Duffy, Robert A Smith
Thorax|June 30, 2018
Lung cancer CT screening: are we ready to consider screening biennially in a subgroup of low-risk individuals?John K Field, Stephen W Duffy
The New England Journal of Medicine|January 21, 2011
More on screening mammographyStephen W Duffy, Robert A Smith
The Lancet. Oncology|March 25, 2016
Lung cancer CT screening: is annual screening necessary?John K Field, Stephen W Duffy
The Lancet Regional Health. Europe|December 24, 2021
Understanding the lung cancer mortality reductions produced by low-dose CT screening-Authors' replyStephen W Duffy, John K Field
Pageof 30